Immune Regulation News Volume 7.12 | Apr 10 2015

    0
    83
    Immune Regulation News 7.12 April 10, 2015

    Immune Regulation News

         In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
    Like Us on Facebook  IRN on Twitter

     
    TOP STORY
    How Immune Cells Facilitate the Spread of Breast Cancer
    Researchers discovered that certain immune cells are persuaded by breast tumors to facilitate the spread of cancer cells. The tumor sends out signaling molecules that through a number of steps cause the immune system to produce lots of neutrophils. These neutrophils are able to block the actions of T cells. [Press release from the Netherlands Cancer Institute discussing online publication in Nature] Press Release | Abstract
    Enter to Win a Travel Support Award to ISSCR2015!

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    The Receptor TREML4 Amplifies TLR7-Mediated Signaling during Antiviral Responses and Autoimmunity
    Macrophages from Treml4−/− mice were hyporesponsive to Toll-like receptor 7 (TLR7) agonists and failed to produce type I interferons due to impaired phosphorylation of the transcription factor STAT1 by the mitogen-activated protein kinase p38 and decreased recruitment of the adaptor MyD88 to TLR7. [Nat Immunol]
    Abstract | Press Release

    Responsiveness of B Cells Is Regulated by the Hinge Region of IgD
    The authors suggest that the increased immunoglobulin D (IgD)/IgM ratio on conventional B-2 cells is important for preferential immune responses to antigens in immune complexes, and that the increased IgM expression on B-1 cells is essential for B-1 cell homeostasis and function. [Nat Immunol] Abstract

    T Follicular Helper Cells Have Distinct Modes of Migration and Molecular Signatures in Naive and Memory Immune Responses
    Scientists showed that primary helper follicular T cells segregate into follicular mantle and germinal center subpopulations that display distinct gene expression signatures. [Immunity]
    Abstract | Graphical Abstract | Press Release

    Regulation of Obesity-Related Insulin Resistance with Gut Anti-inflammatory Agents
    Researchers showed that the gut immune system is altered during high-fat diet feeding and is a functional regulator of obesity-related insulin resistance that can be exploited therapeutically. Obesity induces a chronic phenotypic pro-inflammatory shift in bowel lamina propria immune cell populations. [Cell Metab]
    Full Article | Graphical Abstract | Press Release

    The Prostaglandin D2 Receptor CRTH2 Regulates Accumulation of Group 2 Innate Lymphoid Cells in the Inflamed Lung
    The authors provide the first demonstration that expression of the prostaglandin D2 receptor CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) regulates the in vivo accumulation of group 2 innate lymphoid cells in the lung. [Mucosal Immunol] Abstract

    DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
    Scientists demonstrate through transcriptional profiling and functional studies that the activating receptor DNAM-1 (CD226) identifies two distinct natural killer (NK) cell functional subsets: DNAM-1+ and DNAM-1− NK cells. [Cell Rep] Full Article | Graphical Abstract

    Development of a Cell System for siRNA Screening of Pathogen Responses in Human and Mouse Macrophages
    To develop an assay platform for high-throughput analysis of macrophage activation by pathogenic stimuli, the authors generated reporter systems in human and mouse macrophages with dynamic readouts for NF-κB and/or TNF-α responses. [Sci Rep] Full Article

    Conserved and Divergent Aspects of Human T-Cell Development and Migration in Humanized Mice
    Researchers found that both conventional T-cell development and intra-thymic migration patterns in humanized mice closely resemble human thymopoiesis. They showed that developing human thymocytes engage in short, serial interactions with other human hematopoietic-derived cells. [Immunol Cell Biol] Full Article

    Macrophages Play an Essential Role in Antigen-Specific Immune Suppression Mediated by T CD8+ Cell-Derived Exosomes
    Researchers investigated the role of macrophages (Mφ) in T CD8+ suppressor cell-exosome-mediated antigen-specific suppression as well as modulation of Mφ antigen-presenting function in humoral and cellular immunity by suppressive exosomes. [Immunology] Abstract

    Inhibiting Macrophage Proliferation Suppresses Atherosclerotic Plaque Inflammation
    Because macrophage proliferation was recently shown to dominate macrophage accumulation in advanced plaques, locally inhibiting macrophage proliferation may reduce plaque inflammation and produce long-term therapeutic benefits. To test this hypothesis, scientists used nanoparticle-based delivery of simvastatin to inhibit plaque macrophage proliferation in apolipoprotein E-deficient mice with advanced atherosclerotic plaques. [Sci Adv] Full Article | Press Release

    Don’t forget to subscribe to Human Immunology News and Immunology of Infectious Disease News!

    Perform automated cell isolation from up to 16 samples at once with RoboSepâ„¢-16.

     
    REVIEWS
    The Development and In Vivo Function of T Helper 9 Cells
    The authors summarize the current understanding of the contribution of T helper 9 (TH9) cells to both effective immunity and immunopathological disease, and propose that TH9 cells could be targeted for the treatment of allergic and autoimmune disease. [Nat Rev Immunol] Abstract

    Immune-Mediated Mechanisms Influencing the Efficacy of Anticancer Therapies
    The authors discuss the impact of innate and adaptive immune cells on the success of anticancer therapy. In this context they examine the opportunities to exploit host immune responses to boost tumor clearing, and highlight the challenges facing the treatment of advanced metastatic disease. [Trends Immunol] Abstract

    Visit our reviews page to see a complete list of reviews in the immune regulation research field.

    Your Favorite Immunology Newsletters Are Now on Facebook! Like Us Today!

     
    SCIENCE NEWS
    Inovio Pharmaceuticals HPV Immunotherapy Activates Robust In Vivo T Cell Responses in Head & Neck Cancer Patients
    Inovio Pharmaceuticals, Inc. announced preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in three of four patients with head and neck cancer associated with human papillomavirus (HPV) types 16 and 18. [Press release from Inovio Pharmaceuticals, Inc. discussing research presented at the World Vaccine Congress 2015, Washington DC] Press Release

    From our sponsor: Free human hematopoietic progenitors wallchart. Request your copy.

     
    INDUSTRY NEWS
    American Cancer Society Awards New Research and Training Grants
    The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 100 national research and training grants totaling more than $45.6 million in the first of two grant cycles for 2015. [American Cancer Society, Inc.] Press Release

    Memorial Sloan Kettering Opens Pediatric CAR T Cell Clinical Trial
    Researchers from Memorial Sloan Kettering Cancer Center are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells. [Memorial Sloan Kettering Cancer Center] Press Release

    Advaxis and Merck Announce Initiation of Enrollment in the Phase I/II Study of ADXS-PSA in Combination with Anti-PD-1 Therapy, KEYTRUDA® (Pembrolizumab), for the Treatment of Advanced Prostate Cancer
    Advaxis, Inc. and Merck announced that enrollment has initiated in the Phase I/II clinical trial evaluating the combination of ADXS-PSA, an investigational Lm-LLO immunotherapy, and KEYTRUDA® in patients with previously treated, metastatic castration-resistant prostate cancer. [Advaxis, Inc.] Press Release

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Nordic Life Sciences Days 2015
    September 9-10, 2015
    Stockholm, Sweden

    NEW 14th International Workshop on Langerhans Cells
    November 5-8, 2015
    Kyoto, Japan

    Visit our events page to see a complete list of events in the immune regulation community.

     
    JOB OPPORTUNITIES
    NEW Senior Scientist – Immunology (National Institute of Immunology)

    NEW Postdoctoral Position – Immunology/Rheumatology (University of California at Davis)

    NEW Assistant Professor – Immunology (Northwestern University)

    NEW Assistant Professor – Immunology (Dana-Farber Cancer Institute)

    Manufacturing Manager – Cell Therapy (Opexa Therapeutics)

    Postdoctoral Research Fellow – Molecular Aspects of Autoimmunity (Singapore Immunology Network A*STAR)

    PhD Studentship – Mouse Models of Asthma (University of Queensland)

    Postdoctoral Researcher – Tumor Immunology and Immunotherapy (Cleveland Clinic Lerner Research Institute)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Immune Regulation News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Immune Regulation News: Archives | Events | Contact Us